Eisai, Purdue Pharma declare positive results of SUNRISE 2

Pharma |  News | 0 Comment | 17 Oct, 2018

Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a long-term Phase 3 efficacy and safety evaluation of lemborexant, an investigational agent for sle...Read more

Pharma firm to pay $1.3B fine for vaccine scandal

Pharma |  News | 0 Comment | 17 Oct, 2018

Changchun Changsheng Life Sciences Ltd has been charged with a huge fine of $1.3 billion for falsifying production records in a scandal that prompted a nationwide crackdown on the vaccine i...Read more

Eisai signs pact with Eurofarma for anti-obesity agent

Pharma |  News | 0 Comment | 16 Oct, 2018

Eisai Co., Ltd. has entered into an agreement with Eurofarma Laboratorios, to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in 17 coun...Read more

Innovus Pharma receives approval from Amazon for expansion in Japan

Pharma |  News | 0 Comment | 15 Oct, 2018

Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men...Read more

GHIT Fund partners with Ono Pharmaceutical

Pharma |  News | 0 Comment | 15 Oct, 2018

The Global Health Innovative Technology (GHIT) Fund has welcomed Ono Pharmaceutical Co., Ltd. (Ono) to join GHIT as a new affiliate partner. Ono, headquartered in Osaka, Japan, is a re...Read more

MGC Pharma receives TGA approval to market epilepsy drug in Australia

Pharma |  News | 0 Comment | 11 Oct, 2018

Australia's MGC Pharmaceuticals is pleased to announce the receipt of formal authorisation for the availability of its product CannEpil for supply in Australia through specialist prescriber...Read more

Ionis, Roche unite to treat Complement-Mediated Diseases

Pharma |  News | 0 Comment | 11 Oct, 2018

Ionis Pharmaceuticals announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases. This collaboration will leverage Ionis' leadership...Read more

Lilly India enters the autoimmune segment with Olumiant

Pharma |  News | 0 Comment | 10 Oct, 2018

Eli Lilly and Company (India) Pvt. Ltd. (Lilly India) has announced the launch of Olumiant (baricitinib). This announcement is taking place few days ahead of World Arthritis Day (October 12...Read more

ASLAN to present posters for Medical Oncology Congress

Pharma |  News | 0 Comment | 09 Oct, 2018

Singapore – ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States...Read more

Novan inks $11M deal with Japanese firm

Pharma |  News | 0 Comment | 09 Oct, 2018

US based pharmaceutical company Novan has announced an extended license agreement with Sato Pharmaceutical Co, a Japanese prescription company specializing in dermatology. Novan has scored...Read more

CASI Pharmaceuticals appoints new president for China Operations

Pharma |  News | 0 Comment | 08 Oct, 2018

CASI Pharmaceuticals, a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients i...Read more

Roche receives US FDA nod for blockbuster Hemlibra

Pharma |  News | 0 Comment | 08 Oct, 2018

Roche recently announced  that the US Food and Drug Administration (FDA) has approved Hemlibra (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding ...Read more

Japan MHLW grants orphan designation to Axicabtagene Ciloleucel

Pharma |  News | 0 Comment | 08 Oct, 2018

Daiichi Sankyo Company, Limited has announced that axicabtagene ciloleucel (formerly KTE-C19) has been granted Orphan Drug designation by the Japan Ministry of Health, Labour and Welfare (M...Read more

Aptar Pharma brings new respiratory drug delivery device

Pharma |  News | 0 Comment | 07 Oct, 2018

Drug delivery systems provider Aptar Pharma has introduced a new portable, drug delivery device called PureHale to help relieve the symptoms of upper respiratory system disorders. The new ...Read more

Pharma conference to focus on AI based drug development

Pharma |  News | 0 Comment | 04 Oct, 2018

The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) and the Korea Health Industry Development Institute (KHIDI) would be holding “AI Pharma Korea Conference&rdqu...Read more

Exscientia appoints Georgy Egorov as CFO

Pharma |  News | 0 Comment | 04 Oct, 2018

Exscientia, announced the appointment of Mr Georgy Egorov as Chief Financial Officer (CFO) effective immediately. Georgy brings extensive experience in global capital markets and inve...Read more

CANbridge Pharma submits NDA for NERLYNX in China

Pharma |  News | 0 Comment | 02 Oct, 2018

CANbridge Pharmaceutical Inc., a biopharmaceutical company developing Western drug candidates in China and North Asia, announced that it has filed a New Drug Application (NDA) to China&rsqu...Read more

GC Pharma receives approval for seasonal influenza vaccine

Pharma |  News | 0 Comment | 01 Oct, 2018

GC Pharma (formerly known as Green Cross) has announced that it has received approval from the South Korean Ministry of Food and Drug Safety (MFDS) expanding the indication for GCFLU Quadri...Read more